Officinae Bio’s AI-driven sequence optimization expands Maravai’s family of brands, enabling rapid, cost-effective nucleic acid therapy development SAN DIEGO — Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that it has completed its previously announced acquisition of Officinae Bio’s DNA and RNA business. This […]

New single cell and spatial innovations extend 10x Genomics’ technology and performance leadership across all three platforms PLEASANTON, Calif. — At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced a series of new product innovations to solidify its position as […]

Expanded collaboration enables richer, more cost-effective biological insights from single cell workflows Oxford Nanopore Technologies announced today its expanded collaboration with 10x Genomics, Inc. to enable seamless compatibility between their latest technologies, bringing more accurate, cost-effective and accessible insights to single-cell transcriptomics research. The certified compatibility is between 10x Genomics’ latest Chromium Universal GEM-X 3’ and GEM-X […]

BOSTON — Volta Labs, a leading genomics applications company, and Ginkgo Bioworks, (NYSE: DNA), which is building a leading platform for cell programming and biosecurity, today announced the integration of the Callisto™ Sample Prep System at Ginkgo Bioworks as part of the routine Illumina sequencing workflow. “I like the Apps and the App Store concept on Callisto. It […]

BILLERICA, Mass. — Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has appointed Laura Francis to serve on its board as an independent director, effective as of February 18, 2025. Ms. Francis is also expected to join Bruker’s Audit Committee as a financial expert after Bruker’s annual shareholder meeting at the end of […]

SAN DIEGO — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today the closing of its acquisition by an affiliate of Deerfield Management Company, L.P. On December 23, 2024, Singular Genomics announced that Deerfield had signed a definitive agreement to […]

PROVIDENCE, R.I. — Nabsys 2.0, LLC (Nabsys) and Hitachi High-Tech America, Inc. (HTA) have revealed the awardees of their OhmX Rapid Application to Market Penetration User Partnership, or OhmX RAMP UP, Grant Program. The program is focused on making structural variation detection more accessible to human genomics researchers by providing Nabsys’ OhmX platform on consignment to […]

Enspyre is a next generation sequencing (NGS) preparation technology enabling higher sensitivity variant calling from a fraction of the data CAMBRIDGE, UK and RESEARCH TRIANGLE PARK, NORTH CAROLINA, USA — Biofidelity, a leader in innovative genomic solutions, will present launch details for Enspyre®, a novel target enrichment technology with a broad spectrum of potential applications […]

The “High Dimensional Biology Unlocked” webinar showcases initial users and application of the first ever natively paired spatial multiomic platform Company to present five abstracts at the 2025 annual AGBT conference highlighting AVITI24’s capacity to unlock complex biological insights SAN DIEGO, Ca. —  Element Biosciences, Inc., a company democratizing access to advanced life science solutions, […]

Builds on Year of Achievement, with Exciting Catalysts Coming in 2025 Funding led by Northpond Ventures and Breakout Ventures WATERTOWN, Mass. — EnPlusOne Biosciences, Inc., a biotechnology company harnessing the power of enzymes to deliver better RNA at scale, today announced that it had raised additional funding to scale and drive continued technical advancements of […]